Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
62 hedge funds and large institutions have $390M invested in Amryt Pharma plc American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 14 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 15
3% more capital invested
Capital invested by funds: $379M → $390M (+$11.5M)
5% less funds holding
Funds holding: 65 → 62 (-3)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Athyrium Capital Management
New York
|
+$46.8M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$3.1M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.89M |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$2.7M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$2.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$6.24M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.79M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.74M |
| 4 |
BC
Bruce & Co
Chicago,
Illinois
|
-$996K |
| 5 |
Millennium Management
New York
|
-$598K |
AMYT Hedge Fund Activity: Q4 2021 in Review
62 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q4 2021, worth a combined $390M — up 3% from $379M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of AMYT and 12 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 17 added.
The largest buyer was Athyrium Capital Management, adding an estimated $46.8M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $6.24M sold.
- 62 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q4 2021, down from 65 in Q3 2021.
- Funds reported $390M of Amryt Pharma plc American Depositary Shares stock for Q4 2021, up 3% quarter-over-quarter.
- 12 funds opened new Amryt Pharma plc American Depositary Shares positions in Q4 2021 and 14 closed out, a net change of -2 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q4 2021 was Athyrium Capital Management, an estimated $46.8M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q4 2021 was Baker Bros. Advisors, an estimated $6.24M sold.
Based on aggregated 13F filings for Q4 2021.